Selected Grants
Harmony PAS
Clinical TrialPrincipal Investigator · Awarded by Medtronic, Inc. · 2022 - 2031Fontan Udenafil Exercise Longitudinal Assessment Trial (the FUEL-2 Study) Phase 3 study, to evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of phosphodiesterase type 5 (PDE5)
Clinical TrialPrincipal Investigator · Awarded by Mezzion Pharma Co., LTD · 2024 - 2026COngenital Multicenter trial of Pulmonic vAlve dysfunction Studying the SAPIEN 3 interventIONal THV Post-Approval Study
Clinical TrialPrincipal Investigator · Awarded by Edwards Lifesciences Corporation · 2021 - 2026Multicenter Post-Approval Study of Congenital Pulmonic Valve Dysfunction Studying the Edwards SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra Adaptive Prestent
Clinical TrialPrincipal Investigator · Awarded by Edwards Life Sciences Corporation · 2022 - 2025COngenital Multicenter trial of Pulmonic vAlve dysfunction Studying the SAPIEN 3 interventIONal THV
Clinical TrialPrincipal Investigator · Awarded by Edwards Lifesciences Corporation · 2016 - 2024External Relationships
- Edwards Lifesciences
- Medtronic
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.